Bipartisan legislation advancing in the U.S. Senate and the U.S. House of Representatives known as the “BIOSECURE Act” (“the Act”) has the potential to significantly restrict the ability of biotechnology companies to collaborate with certain Chinese companies without losing the ability to contract with the U.S. government. Following the same model that was used to target Chinese telecommunications companies in the late 2010s, the Act would prohibit federal “executive agencies” from contracting with or extending…
On April 24, 2024, President Biden signed into law a national security package (H.R. 815) that includes the 21st Century Peace through Strength Act, the fourth pillar of a broader foreign aid package to assist Israel, Ukraine, and the Indo-Pacific. The law contains numerous sanctions and trade-related provisions. In this blog post, we are summarizing the provisions that are most relevant to multinational companies seeking to comply with applicable trade rules and mitigate risks, which…
On Saturday, April 20, 2024, after months of negotiations and many twists and turns, the US House of Representatives passed the 21st Century Peace through Strength Act (H.R. 8038). This bill, which is the fourth pillar of a broader foreign aid package to assist Israel, Ukraine, and the Indo-Pacific, contains numerous sanctions and trade-related national security measures. After each of the four foreign security bills were passed on Saturday, they were combined into one package…
On December 22, 2023, President Biden signed into law the National Defense Authorization Act (“NDAA”) for Fiscal Year 2024 (P.L. 118-31). A must-pass piece of legislation that funds Department of Defense (“DoD”) operations on an annual basis, the NDAA is a frequent vehicle for trade-related provisions and legislative changes affecting DoD acquisition policies with direct implications for government contractors. The measure includes a number of provisions relating to US export controls, sanctions, and supply chain…